Market Overview The US America Pouchitis Treatment Market is advancing as biologic therapies originally developed for inflammatory bowel disease find increasing application in refractory and chronic antibiotic-dependent pouchitis cases that fail conventional treatment. While most pouchitis responds to antibiotics, a significant subset of patients develops chronic, relapsing, or refractory...